Lebanon, NH, United States of America

Eric Krauland

USPTO Granted Patents = 20 

 

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 35(Granted Patents)


Location History:

  • Cambridge, MA (US) (2013)
  • Lebanon, NH (US) (2013 - 2023)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
20 patents (USPTO):

Title: The Innovative Contributions of Eric Krauland in Antibody Development

Introduction

Eric Krauland, based in Lebanon, NH, has established himself as a significant figure in the field of biotechnology through his innovative work and numerous patents. With a total of 20 patents to his name, Krauland has made notable contributions to the advancements in antibody therapies.

Latest Patents

Among his latest patents is a groundbreaking method for creating polyclonal mixtures of antibodies. This method involves broadening the epitopic coverage of an antigen of interest by contacting a first sample of the antigen with a plurality of host cells expressing a library of antibodies. The process allows for the collection of host cells expressing antibodies that bind to the antigen, ultimately resulting in a polyclonal mixture. Additionally, Krauland has developed dual specificity antibodies that target PD-L1 and PD-L2, offering new therapeutic avenues for treating cancers associated with these proteins.

Career Highlights

Throughout his career, Eric Krauland has worked with prominent companies in the biotechnology sector, including Adimab, LLC and Merrimack Pharmaceuticals, Inc. His work in these organizations has been pivotal in advancing research and development related to antibody therapies.

Collaborations

Eric has collaborated with industry experts such as Michael Feldhaus and Neeraj Kohli. These collaborations have fostered an environment of innovation and creativity, furthering the potential of antibody-based treatments.

Conclusion

Eric Krauland stands out as a dedicated inventor whose work has the potential to significantly impact the field of antibody therapy. His inventions not only showcase his deep expertise but also reflect the collaborative spirit that drives innovation in biotechnology. As he continues to build upon his impressive portfolio of patents, Krauland remains a prominent figure in the pursuit of new medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…